Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other financing activities: 2019-2025

Historic Other financing activities for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$167,000.

  • Biodesix's Other financing activities fell 32.54% to -$167,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$724,000, marking a year-over-year decrease of 163.27%. This contributed to the annual value of -$445,000 for FY2024, which is 153.42% down from last year.
  • According to the latest figures from Q3 2025, Biodesix's Other financing activities is -$167,000, which was up 12.11% from -$190,000 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Other financing activities ranged from a high of $2.1 million in Q2 2022 and a low of -$198,000 during Q1 2025.
  • Its 3-year average for Other financing activities is -$16,700, with a median of -$103,000 in 2024.
  • As far as peak fluctuations go, Biodesix's Other financing activities skyrocketed by 208,400.00% in 2022, and later plummeted by 12,700.00% in 2024.
  • Quarterly analysis of 5 years shows Biodesix's Other financing activities stood at $568,000 in 2021, then spiked by 159.86% to $1.5 million in 2022, then tumbled by 99.25% to $1,000 in 2023, then plummeted by 12,700.00% to -$169,000 in 2024, then crashed by 32.54% to -$167,000 in 2025.
  • Its last three reported values are -$167,000 in Q3 2025, -$190,000 for Q2 2025, and -$198,000 during Q1 2025.